Exact Sciences Corp. (Nasdaq: EXAS), a molecular diagnostics company focused on colorectal cancer, today announced the appointment of Laura S. Stoltenberg as chief commercial officer. In this role, she will be responsible for developing and executing Exact's global commercial strategies and join the company’s executive management team.
Ms. Stoltenberg brings nearly two decades of experience in sales, marketing, business development and general management to her role at Exact. She was most recently vice president and general manager of GE Healthcare Lunar, a global leader in bone densitometry and body composition instruments. While at Lunar, Ms. Stoltenberg expanded the business’s market leadership, increased its international presence, improved operating profitability and oversaw the launch of several new products, including a revolutionary body composition test used in the assessment of cardio-metabolic risk.
“We are pleased to welcome Laura to Exact’s management team,” said Kevin T. Conroy, Exact’s president and chief executive. “Laura’s broad range of leadership experiences in strategic marketing, business development and international business are a great fit for Exact and will help us capture the significant opportunities we’ve identified. She will be a key leader in the company’s execution on our priorities as we move towards the completion of our clinical trial, FDA submission and beyond.”
“I am excited to join the team at Exact, as we work to bring the Cologuard test to market,” Ms. Stoltenberg said. “The chance to positively affect the outcomes of tens of thousands of colorectal cancer patients is very real. I look forward to working with Exact’s talented team to provide Cologuard to patients and physicians worldwide.”Before being appointed Lunar’s general manager in 2007, Ms. Stoltenberg served as director of business development at GE Healthcare, where she led strategy development and acquisition activities for four of its business units, including medical diagnostics. Ms. Stoltenberg also served as manager, business development at GE Healthcare’s IT business unit and in several commercial positions at GE Industrial Systems.
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV